Congresswoman Caraveo Joins in Introducing Legislation to Reaffirm FDA's Approval Authority
April 13, 2023
April 13, 2023
THORNTON, Colorado, April 13 -- Rep. Yadira Caraveo, D-Colorado, issued the following news release:
Congresswoman Yadira Caraveo, M.D. (CO-08) joined in introducing legislation to reaffirm that Mifepristone, one of two drugs used in the medication abortion regimen, was appropriately approved by the US Food and Drug Administration (FDA). The Protecting Reproductive Freedom Act also reaffirms that this approval preempts any state law seeking to prohibit or restrict access to the abort . . .
Congresswoman Yadira Caraveo, M.D. (CO-08) joined in introducing legislation to reaffirm that Mifepristone, one of two drugs used in the medication abortion regimen, was appropriately approved by the US Food and Drug Administration (FDA). The Protecting Reproductive Freedom Act also reaffirms that this approval preempts any state law seeking to prohibit or restrict access to the abort . . .